Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.

Autor: Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Electronic address: marc.ferrante@uzleuven.be., D'Haens G; Inflammatory Bowel Disease Centre, Amsterdam University Medical Center, Amsterdam, Netherlands., Jairath V; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada., Danese S; Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital, Milan, Italy., Chen M; Division of Gastroenterology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Ghosh S; APC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland., Hisamatsu T; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan., Kierkus J; Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, The Children's Memorial Health Institute, Warsaw, Poland., Siegmund B; Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany., Bragg SM; Eli Lilly and Company, Indianapolis, IN, USA., Crandall W; Eli Lilly and Company, Indianapolis, IN, USA., Durand F; Eli Lilly and Company, Indianapolis, IN, USA., Hon E; Eli Lilly and Company, Indianapolis, IN, USA., Lin Z; Eli Lilly and Company, Indianapolis, IN, USA., Lopes MU; Eli Lilly and Company, Indianapolis, IN, USA., Morris N; Eli Lilly and Company, Indianapolis, IN, USA., Protic M; Eli Lilly and Company, Indianapolis, IN, USA., Carlier H; Eli Lilly and Company, Indianapolis, IN, USA., Sands BE; Dr Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Publikováno v: Lancet (London, England) [Lancet] 2024 Dec 14; Vol. 404 (10470), pp. 2423-2436. Date of Electronic Publication: 2024 Nov 21.

Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn's Disease: A Real-World Global Study.

Autor: Atreya R; Medical Department 1, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany., Redondo I; Medical Affairs, Eli Lilly and Company, Lisbon, Portugal., Streit P; Global New Product Planning, Eli Lilly and Company, Vernier, Switzerland., Protic M; Medical Affairs, Eli Lilly and Company, Vernier, Switzerland., Hartz S; Value, Evidence and Outcomes - International, Eli Lilly and Company, Bracknell, UK., Gurses G; Reimbursement Access, Eli Lilly and Company, Istanbul, Turkey., Knight H; Autoimmune Franchise, Adelphi Real World, Bollington, UK., Barlow S; Statistics & Data Analytics, Adelphi Real World, Bollington, UK., Harvey N; Autoimmune Franchise, Adelphi Real World, Bollington, UK., Hunter Gibble T; Value, Evidence and Outcomes, Eli Lilly and Company, Indianapolis, USA.

Publikováno v: Crohn's & colitis 360 [Crohns Colitis 360] 2024 Aug 10; Vol. 6 (3), pp. otae047. Date of Electronic Publication: 2024 Aug 10 (Print Publication: 2024).

The behavior of the radar parameters of cumulonimbus clouds during cloud seeding with AgI

Autor: Vujović, D. ^{a, ⁎}, Protić, M. ^b

Publikováno v: In Atmospheric Research 1 June 2017 189:33-46

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

EORTC 1409 GITCG/ESSO 01 - A prospective colorectal liver metastasis database for borderline or initially unresectable diseases (CLIMB): Lessons learnt from real life. From paradigm to unmet need.

Autor: Collienne M; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. Electronic address: maike.collienne@eortc.org., Neven A; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium; Luxembourg Institute of Health, Competence Center for Methodology and Statistics, Strassen, Luxembourg., Caballero C; Breast International Group (BIG-aisbl), Brussels, Belgium., Kataoka K; Division of Lower GI, Department of Gastroenterological Surgery, School of Medicine, Hyogo Medical University, Hyogo, Japan., Carrion-Alvarez L; Hospital Universitario de Fuenlabrada, Madrid, Spain., Nilsson H; Karolinska Institutet, Department of Clinical Sciences Danderyd, Stockholm, Sweden., Désolneux G; Surgical Oncology, Institut Bergonie, Bordeaux, France., Rivoire M; Centre Léon Bérard, Lyon, France., Ruers T; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Gruenberger T; Clinic Favoriten, HPB Center, Health Network Vienna and Sigmund Freud University, Vienna, Austria., Protic M; University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia and Oncology Institute of Vojvodina, Sremska Kamenica, Serbia., Troisi RI; Dept. of Human Structure and Repair, Ghent University, Belgium; Division of HPB, Minimally Invasive and Robotic Surgery, Renal Transplantation Service, Dept. of Clinical Medicine and Surgery, Federico II University Hospital Naples, Italy., Primavesi F; Department of Visceral, Transplantation and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria; Department of General, Visceral and Vascular Surgery, Salzkammergutklinikum, Austria., Staettner S; Department of Visceral, Transplantation and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria; Department of General, Visceral and Vascular Surgery, Salzkammergutklinikum, Austria., Rahbari N; Department of Surgery, Universitätsmedizin Mannheim, Mannheim, Germany., Schnitzbauer A; Universitätsklinikum Frankfurt Goethe-Universität Frankfurt Am Main Klinik für Allgemein- und Viszeralchirurgie, Frankfurt, Germany., Malik H; Aintree University Hospital NHS Trust, Liverpool, United Kingdom., Swijnenburg RJ; Leiden University Medical Center, Leiden, Netherlands; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Mauer M; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Ducreux M; Gustave Roussy, Université Paris Saclay, Inserm, U1279, France., Evrard S; Institut Bergonié, Université de Bordeaux, INSERM, U1312, France. Electronic address: s.evrard@bordeaux.unicancer.fr.

Publikováno v: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Nov; Vol. 49 (11), pp. 107081. Date of Electronic Publication: 2023 Sep 25.